[DPHARMA] Director APPOINTMENT - AMIRUL FEISAL BIN WAN ZAHIR on 13-Jun-2011

Stock
[DPHARMA] : DUOPHARMA BIOTECH BERHAD
Announcement Date
13-Jun-2011
Board Member Information:
Date of Change
13-Jun-2011
Type of Change
APPOINTMENT
Designation
Director
Directorate
Non Independent & Non Executive
Name
AMIRUL FEISAL BIN WAN ZAHIR
Age
41
Nationality
Malaysian
Qualification
(i) Bachelor of Science Economics (Accounting and Finance), London School of Economics, University of London.
(ii) Associate Member, Institute of Chartered Accountants England and Wales.
Working Experience
Prior to Encik Amirul Feisal’s secondment to CCM as Executive Director, he was the Executive Vice President for Special Projects in Permodalan Nasional Berhad. Encik Amirul Feisal started his career in KPMG Plc in the Audit Division based in London and left as an Assistant Manager to Schroders Investment Banking in Kuala Lumpur in 1997. He remained at Schroders (later acquired by Salomon Smith Barney and subsequently renamed Citigroup Global Markets) until 2004. During that period Encik Amirul Feisal worked in various departments within the Investment Banking Division including the Project Finance and Privatisation Department, Corporate Finance Group, Mergers & Acquisition Group and the Industrial/Large Cap Group based in Kuala Lumpur, Singapore and Hong Kong. In 2004, Encik Amirul Feisal joined BinaFikir Sdn Bhd, a Malaysian-based boutique advisory firm as a shareholder and Executive Director. He was Managing Director, Head Investment Banking for Maybank Investment Bank Bhd from 2008 until September 2009.
Directorship of Public Companies
Chemical Company of Malaysia Berhad
Family Relationship
None
Conflict of Interest
None
Interest
None
Market Buzz
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment